Global microbiome diagnostic market is anticipated to grow at a CAGR of 11.4% during the forecast period (2024-2031). The market growth is attributed to the growing adoption of advanced technologies such as metagenomics,16S rRNA Sequencing, shotgun metagenomics, and metatranscriptomics for microbiome detection. For instance, in November 2023, QIAGEN launched Microbiome WGS SeqSets, a comprehensive Sample to Insight workflow designed to provide an easy-to-use solution that maximizes efficiency and reproducibility in microbiome research. The QIAamp PowerFecal Pro WGS SeqSets and the DNeasy PowerSoil Pro WGS SeqSets offer unified solutions for gut and soil samples.
Browse the full report description of “Microbiome Diagnostic Market Size, Share & Trends Analysis Report by Product (Reagents & Kits, and Instruments), by Technology (16S rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics, and Other), and by End-Users (Hospitals, Academic and Research Institutes and Biotechnology, and Pharmaceutical Companies) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/microbiome-diagnostic-market
Market players partnered for advanced method that enables microbiologists to evaluate gut microbiome analysis and detect the abundance of microbes in gut for effective diagnosis. In June 2021, Illumina and Microba Life Sciences partnered to accelerate microbiome research. The partnership brings together Illumina’s NGS tools and Microba’s high-quality proprietary gut microbiome analysis platform to generate the accurate metagenomic data that researchers require to fuel discoveries.
Microbial population for diagnosis, metatranscriptomics analysis combines the most innovative next- and third-generation sequencing technology with thorough bioinformatics analysis. This results in the collective microbial transcriptome of a sample. For example, CD Genomics offers a metranscriptomics platform that uses the most innovative next and third-generation sequencing technologies along with integrated bioinformatics analysis to elucidate three aspects of a microbial community including gene activity diversity, gene expression abundance, and differential gene expression analysis.
Market Coverage
• The market number available for – 2023-2031
• Base year- 2023
• Forecast period- 2024-2031
• Segment Covered-
o By Product
o By Technology
o By End-Users
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes Bio-Rad Laboratories, Inc., Illumina, Inc., Merck KGaA, Takara Bio Inc., and Thermo Fisher Scientific Inc., among others.
Key questions addressed by the report.
Global Microbiome Diagnostic Market Report Segment
By Product
By Technology
By End-Users
Global Microbiome Diagnostic Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• The Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/microbiome-diagnostic-market